Professor Ross Davey

Director, Bill Walsh Cancer Research Laboratories
Medicine, Northern Clinical School

Telephone +61 2 9926 4727
Fax +61 2 9926 5253

Map

Selected grants

2009

  • The role of IQGAP1 in actively migrating glioma cells and its regulation by MiR-124; McDonald K, Bennett M, Davey R, Robinson B; Cancer Council New South Wales/Research Project Grants.

2005

  • Inverted Fluorescence Microscopy: A sensitive method used to visualise protein expression in live cells; Jackson C, Davey R, Little C, Morris J, Gallery E; BLO DETYA National School Drug Education Strategy/RIGB Grant.

Selected publications

Download citations: PDF RTF Endnote

Book Chapters

  • Stordal, B., Pavlakis, N., Davey, R. (2009). A systematic alalysis of oxaliplatin or paclitaxel salvage chemotherapy. In Andrea Bonetti, Roberto Leone,Franco M Muggia, Stephen B Howell (Eds.), Platinum and Other Heavy Metal Compounds in Cancer Chemotherapy: Molecular Mechanisms and Clinical Applications, (pp. 225-230). US: Humana Press.
  • Stordal, B., Davey, R. (2009). Regrowth resistance: low-level platinum resistance mediated by rapid recovery from platinum-induced cell-cycle arrest. In Andrea Bonetti, Roberto Leone,Franco M Muggia, Stephen B Howell (Eds.), Platinum and Other Heavy Metal Compounds in Cancer Chemotherapy: Molecular Mechanisms and Clinical Applications, (pp. 171-176). US: Humana Press.

Journals

  • Weir, C., Hudson, A., Moon, E., Ross, A., Alexander, M., Peters, L., Langova, V., Clarke, S., Pavlakis, N., Davey, R., Howell, V. (2014). Streptavidin: a novel immunostimulant for the selection and delivery of autologous and syngeneic tumor vaccines. Cancer Immunology Research, 2(5), 469-479. [More Information]
  • Jaiswal, R., Gong, J., Sambasivam, S., Combes, V., Mathys, J., Davey, R., Grau, G., Bebawy, M. (2012). Microparticle-associated nucleic acids mediate trait dominance in cancer. The FASEB Journal, 26(1), 420-429. [More Information]
  • Kao, S., Harvie, R., Paturi, F., Taylor, R., Davey, R., Abraham, R., Clarke, S., Marx, G., Cullen, M., Kerestes, Z., Pavlakis, N. (2012). The predictive role of serum VEGF in an advanced malignant mesothelioma patient cohort treated with thalidomide alone or combined with cisplatin/gemcitabine. Lung Cancer, 75(2), 248-254. [More Information]
  • Stordal, B., Davey, R. (2009). A systematic review of genes involved in the inverse resistance relationship between cisplatin and paclitaxel chemotherapy: role of BRCA1. Current Cancer Drug Targets, 9(3), 354-365. [More Information]
  • Stordal, B., Davey, R. (2009). ERCC1 expression and RAD51B activity correlate with cell cycle response to platinum drug treatment not DNA repair. Cancer Chemotherapy and Pharmacology, 63(4), 661-672. [More Information]
  • Bromley, R., Oliver, L., Davey, R., Harvie, R., Baldock, C. (2009). Predicting the clonogenic survival of A549 cells after modulated x-ray irradiation using the linear quadratic model. Physics in Medicine and Biology, 54(2), 187-206. [More Information]
  • Stordal, B., Davey, R. (2008). A 39 kDa fragment of endogenous ASK1 suggests specific cleavage not degradation by the proteasome. IUBMB Life, 60(3), 180-184. [More Information]
  • Janneh, O., Hartkoorn, R., Jones, E., Owen, A., Ward, S., Davey, R., Back, D., Khoo, S. (2008). Cultured CD4T cells and primary human lymphocytes express hOATPs: intracellular accumulation of saquinavir and lopinavir. British Journal of Pharmacology, 155(6), 875-883. [More Information]
  • Stordal, B., Davey, R. (2008). Platinum resistance needs the mythbusters. Toxicology Letters, 180(3), 230. [More Information]
  • Stordal, B., Pavlakis, N., Davey, R. (2007). A systematic review of platinum and taxane resistance from bench to clinic: An inverse relationship. Cancer Treatment Reviews, 33(8), 688-703. [More Information]
  • Murphy, S., Boyle, F., Davey, R., Gu, X., Mather, L. (2007). Enantioselectivity of thalidomide serum and tissue concentrations in a rat glioma model and effects of combination treatment with cisplatin and BCNU. Journal of Pharmacy and Pharmacology, 59(1), 105-114. [More Information]
  • Murphy, S., Davey, R., Gu, X., Haywood, M., McCann, L., Mather, L., Boyle, F. (2007). Enhancement of cisplatin efficacy by thalidomide in a 9L rat gliosarcoma model. Journal of Neuro-Oncology, 85(2), 181-189. [More Information]
  • McCann, L., Haywood, M., Ren, B., Simpson, A., Guilhaus, M., Wasinger, V., Raftery, M., Davey, R. (2007). Identification of Vascular Surface Proteins by in Vivo Biotinylation: A Method Sufficiently Sensitive To Detect Changes in Rat Liver 2 Weeks after Partial Hepatectomy. Journal of Proteome Research, 6(8), 3108-3113. [More Information]
  • Stordal, B., Pavlakis, N., Davey, R. (2007). Oxaliplatin for the treatment of cisplatin-resistant cancer: a systematic review. Cancer Treatment Reviews, 33, 347-357. [More Information]
  • Bromley, R., Davey, R., Oliver, L., Baldock, C., Harvie, R. (2006). A preliminary investigation of cell growth after irradiation using a modulated x-ray intensity pattern. Physics in Medicine and Biology, 51(15), 3639-3651. [More Information]
  • Davey, R., Stordal, B., Peters, G. (2006). Similar chromosomal changes in cisplatin and oxaliplatin-resistant sublines of the H69 SCLC cell line are not associated with platinum resistance. Genes Chromosomes and Cancer, 45. [More Information]
  • Jackson, C., Xue, M., Thompson, P., Davey, R., Whitmont, K., Smith, S., Buisson-Legendre, N., Sztynda, T., Furphy, L., Cooper, A., Sambrook, P., March, L. (2005). Activated protein C prevents inflammation yet stimulates angiogenesis to promote cutaneous wound healing. Wound Repair and Regeneration, 13(3), 284-294. [More Information]
  • Stordal, B., Davey, M., Davey, R. (2005). Oxaliplatin induces drug resistance more rapidly than cisplatin in H69 small cell lung cancer cells. Cancer Chemotherapy and Pharmacology, 58(2), 256-265. [More Information]

2014

  • Weir, C., Hudson, A., Moon, E., Ross, A., Alexander, M., Peters, L., Langova, V., Clarke, S., Pavlakis, N., Davey, R., Howell, V. (2014). Streptavidin: a novel immunostimulant for the selection and delivery of autologous and syngeneic tumor vaccines. Cancer Immunology Research, 2(5), 469-479. [More Information]

2012

  • Jaiswal, R., Gong, J., Sambasivam, S., Combes, V., Mathys, J., Davey, R., Grau, G., Bebawy, M. (2012). Microparticle-associated nucleic acids mediate trait dominance in cancer. The FASEB Journal, 26(1), 420-429. [More Information]
  • Kao, S., Harvie, R., Paturi, F., Taylor, R., Davey, R., Abraham, R., Clarke, S., Marx, G., Cullen, M., Kerestes, Z., Pavlakis, N. (2012). The predictive role of serum VEGF in an advanced malignant mesothelioma patient cohort treated with thalidomide alone or combined with cisplatin/gemcitabine. Lung Cancer, 75(2), 248-254. [More Information]

2009

  • Stordal, B., Pavlakis, N., Davey, R. (2009). A systematic alalysis of oxaliplatin or paclitaxel salvage chemotherapy. In Andrea Bonetti, Roberto Leone,Franco M Muggia, Stephen B Howell (Eds.), Platinum and Other Heavy Metal Compounds in Cancer Chemotherapy: Molecular Mechanisms and Clinical Applications, (pp. 225-230). US: Humana Press.
  • Stordal, B., Davey, R. (2009). A systematic review of genes involved in the inverse resistance relationship between cisplatin and paclitaxel chemotherapy: role of BRCA1. Current Cancer Drug Targets, 9(3), 354-365. [More Information]
  • Stordal, B., Davey, R. (2009). ERCC1 expression and RAD51B activity correlate with cell cycle response to platinum drug treatment not DNA repair. Cancer Chemotherapy and Pharmacology, 63(4), 661-672. [More Information]
  • Bromley, R., Oliver, L., Davey, R., Harvie, R., Baldock, C. (2009). Predicting the clonogenic survival of A549 cells after modulated x-ray irradiation using the linear quadratic model. Physics in Medicine and Biology, 54(2), 187-206. [More Information]
  • Stordal, B., Davey, R. (2009). Regrowth resistance: low-level platinum resistance mediated by rapid recovery from platinum-induced cell-cycle arrest. In Andrea Bonetti, Roberto Leone,Franco M Muggia, Stephen B Howell (Eds.), Platinum and Other Heavy Metal Compounds in Cancer Chemotherapy: Molecular Mechanisms and Clinical Applications, (pp. 171-176). US: Humana Press.

2008

  • Stordal, B., Davey, R. (2008). A 39 kDa fragment of endogenous ASK1 suggests specific cleavage not degradation by the proteasome. IUBMB Life, 60(3), 180-184. [More Information]
  • Janneh, O., Hartkoorn, R., Jones, E., Owen, A., Ward, S., Davey, R., Back, D., Khoo, S. (2008). Cultured CD4T cells and primary human lymphocytes express hOATPs: intracellular accumulation of saquinavir and lopinavir. British Journal of Pharmacology, 155(6), 875-883. [More Information]
  • Stordal, B., Davey, R. (2008). Platinum resistance needs the mythbusters. Toxicology Letters, 180(3), 230. [More Information]

2007

  • Stordal, B., Pavlakis, N., Davey, R. (2007). A systematic review of platinum and taxane resistance from bench to clinic: An inverse relationship. Cancer Treatment Reviews, 33(8), 688-703. [More Information]
  • Murphy, S., Boyle, F., Davey, R., Gu, X., Mather, L. (2007). Enantioselectivity of thalidomide serum and tissue concentrations in a rat glioma model and effects of combination treatment with cisplatin and BCNU. Journal of Pharmacy and Pharmacology, 59(1), 105-114. [More Information]
  • Murphy, S., Davey, R., Gu, X., Haywood, M., McCann, L., Mather, L., Boyle, F. (2007). Enhancement of cisplatin efficacy by thalidomide in a 9L rat gliosarcoma model. Journal of Neuro-Oncology, 85(2), 181-189. [More Information]
  • McCann, L., Haywood, M., Ren, B., Simpson, A., Guilhaus, M., Wasinger, V., Raftery, M., Davey, R. (2007). Identification of Vascular Surface Proteins by in Vivo Biotinylation: A Method Sufficiently Sensitive To Detect Changes in Rat Liver 2 Weeks after Partial Hepatectomy. Journal of Proteome Research, 6(8), 3108-3113. [More Information]
  • Stordal, B., Pavlakis, N., Davey, R. (2007). Oxaliplatin for the treatment of cisplatin-resistant cancer: a systematic review. Cancer Treatment Reviews, 33, 347-357. [More Information]

2006

  • Bromley, R., Davey, R., Oliver, L., Baldock, C., Harvie, R. (2006). A preliminary investigation of cell growth after irradiation using a modulated x-ray intensity pattern. Physics in Medicine and Biology, 51(15), 3639-3651. [More Information]
  • Davey, R., Stordal, B., Peters, G. (2006). Similar chromosomal changes in cisplatin and oxaliplatin-resistant sublines of the H69 SCLC cell line are not associated with platinum resistance. Genes Chromosomes and Cancer, 45. [More Information]

2005

  • Jackson, C., Xue, M., Thompson, P., Davey, R., Whitmont, K., Smith, S., Buisson-Legendre, N., Sztynda, T., Furphy, L., Cooper, A., Sambrook, P., March, L. (2005). Activated protein C prevents inflammation yet stimulates angiogenesis to promote cutaneous wound healing. Wound Repair and Regeneration, 13(3), 284-294. [More Information]
  • Stordal, B., Davey, M., Davey, R. (2005). Oxaliplatin induces drug resistance more rapidly than cisplatin in H69 small cell lung cancer cells. Cancer Chemotherapy and Pharmacology, 58(2), 256-265. [More Information]

To update your profile click here. For support on your academic profile contact .